Chair: Reuben Broom
Case 1: Oligometastatic disease - how aggressive should we be
Case 2: Management of small renal masses and ablative therapies
Chair: Reuben Broom
Case 1: Oligometastatic disease - how aggressive should we be
Case 2: Management of small renal masses and ablative therapies